Ingrid Bartsch

1.2k total citations
36 papers, 984 citations indexed

About

Ingrid Bartsch is a scholar working on Molecular Biology, Cell Biology and Hematology. According to data from OpenAlex, Ingrid Bartsch has authored 36 papers receiving a total of 984 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 8 papers in Cell Biology and 5 papers in Hematology. Recurrent topics in Ingrid Bartsch's work include Genomics and Chromatin Dynamics (8 papers), RNA and protein synthesis mechanisms (7 papers) and Carcinogens and Genotoxicity Assessment (5 papers). Ingrid Bartsch is often cited by papers focused on Genomics and Chromatin Dynamics (8 papers), RNA and protein synthesis mechanisms (7 papers) and Carcinogens and Genotoxicity Assessment (5 papers). Ingrid Bartsch collaborates with scholars based in Germany, United States and United Kingdom. Ingrid Bartsch's co-authors include Ingrid Grummt, Anne Kuhn, Hansruedi Glatt, I. Grummt, Barbara Zieger, Kirstin Sandrock, Michael W.H. Coughtrie, Charles N. Falany, Andreas Czich and Andrea Normann and has published in prestigious journals such as Nature, Cell and Nucleic Acids Research.

In The Last Decade

Ingrid Bartsch

36 papers receiving 967 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ingrid Bartsch Germany 18 700 132 117 99 77 36 984
James T. Radek United States 18 470 0.7× 359 2.7× 114 1.0× 28 0.3× 65 0.8× 23 1.1k
Kaoru Nishiyama Japan 14 710 1.0× 84 0.6× 51 0.4× 29 0.3× 198 2.6× 33 1.1k
Yves Dubaquié United States 13 622 0.9× 39 0.3× 64 0.5× 48 0.5× 72 0.9× 16 808
Frédérique Bulle France 14 389 0.6× 84 0.6× 41 0.4× 45 0.5× 47 0.6× 26 723
Kimon C. Kanelakis United States 18 849 1.2× 131 1.0× 133 1.1× 16 0.2× 138 1.8× 26 1.1k
Kelwyn Thomas United States 17 830 1.2× 260 2.0× 95 0.8× 16 0.2× 120 1.6× 28 1.2k
Marcin Ratajewski Poland 18 385 0.6× 129 1.0× 91 0.8× 43 0.4× 76 1.0× 51 853
Samir Acharya United States 9 871 1.2× 80 0.6× 95 0.8× 35 0.4× 104 1.4× 11 1.0k
A. Čihák Czechia 20 1.1k 1.6× 74 0.6× 60 0.5× 59 0.6× 73 0.9× 125 1.6k
L. Dombrovski Canada 10 823 1.2× 94 0.7× 25 0.2× 65 0.7× 20 0.3× 11 918

Countries citing papers authored by Ingrid Bartsch

Since Specialization
Citations

This map shows the geographic impact of Ingrid Bartsch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ingrid Bartsch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ingrid Bartsch more than expected).

Fields of papers citing papers by Ingrid Bartsch

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ingrid Bartsch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ingrid Bartsch. The network helps show where Ingrid Bartsch may publish in the future.

Co-authorship network of co-authors of Ingrid Bartsch

This figure shows the co-authorship network connecting the top 25 collaborators of Ingrid Bartsch. A scholar is included among the top collaborators of Ingrid Bartsch based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ingrid Bartsch. Ingrid Bartsch is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bartsch, Ingrid, et al.. (2017). Novel mutation in two brothers with Hermansky Pudlak syndrome type 3. Blood Cells Molecules and Diseases. 67. 75–80. 9 indexed citations
2.
Kurnik, Karin, Ingrid Bartsch, Andrea Maul‐Pavicic, et al.. (2012). Novel mutation in Hermansky–Pudlak syndrome type 2 with mild immunological phenotype. Platelets. 24(7). 538–543. 15 indexed citations
3.
Sandrock, Kirstin, et al.. (2011). Lethal phenotype of mice carrying aSept11null mutation. Biological Chemistry. 392(8-9). 779–781. 17 indexed citations
4.
Bartsch, Ingrid, Kirstin Sandrock, François Lanza, et al.. (2011). Deletion of human GP1BB and SEPT5 is associated with Bernard-Soulier syndrome, platelet secretion defect, polymicrogyria, and developmental delay. Thrombosis and Haemostasis. 106(9). 475–483. 30 indexed citations
5.
Vannier, Christian, Wolfgang Behnisch, Ingrid Bartsch, et al.. (2010). Novel Homozygous Mutation (c.175delG) in Platelet GlycoproteinITGA2BGene as Cause of Glanzmann's Thrombasthenia Type I. Klinische Pädiatrie. 222(3). 150–153. 4 indexed citations
6.
Bartsch, Ingrid, et al.. (2010). Human endothelial and platelet septin SEPT11: Cloning of novel variants and characterisation of interaction partners. Thrombosis and Haemostasis. 104(12). 1201–1210. 13 indexed citations
7.
Sandrock, Kirstin, et al.. (2009). Septins, a Novel Group of GTP-binding Proteins – Relevance in Hemostasis, Neuropathology and Oncogenesis. Klinische Pädiatrie. 221(3). 150–155. 22 indexed citations
8.
Zieger, Barbara, Allen L. Jenny, Dimitrios A. Tsakiris, et al.. (2009). A large Swiss family with Bernard-Soulier syndrome. Hämostaseologie. 29(2). 161–167. 10 indexed citations
9.
Bartsch, Ingrid, et al.. (2006). Human endothelial cell septins: SEPT11 is an interaction partner of SEPT5. The Journal of Pathology. 210(1). 103–110. 20 indexed citations
10.
Andrae, U., Patricia Kreis, Michael W.H. Coughtrie, et al.. (1999). Activation of propane 2-nitronate to a genotoxicant in V79-derived cell lines engineered for the expression of rat hepatic sulfotransferases. Mutation Research/Genetic Toxicology and Environmental Mutagenesis. 439(2). 191–197. 11 indexed citations
11.
Visser, Theo J., et al.. (1998). Characterization of thyroid hormone sulfotransferases. Chemico-Biological Interactions. 109(1-3). 279–291. 61 indexed citations
12.
13.
Glatt, Hansruedi, Ingrid Bartsch, Michael W.H. Coughtrie, et al.. (1998). Sulfotransferase-mediated activation of mutagens studied using heterologous expression systems. Chemico-Biological Interactions. 109(1-3). 195–219. 61 indexed citations
14.
Bartsch, Ingrid, et al.. (1998). Donna J. Haraway, Modest_Witness@Second_Millennium.FemaleMan©_Meets_OncoMouse™. New York, Routledge, 1997.. Hypatia. 13(2). 165–169. 29 indexed citations
15.
Glatt, Hansruedi, Ingrid Bartsch, Andreas Czich, Albrecht Seidel, & Charles N. Falany. (1995). Salmonella strains and mammalian cells genetically engineered for expression of sulfotransferases. Toxicology Letters. 82-83. 829–834. 20 indexed citations
16.
Czich, Andreas, Ingrid Bartsch, Satish C. Dogra, Sabine Hornhardt, & Hansruedi Glatt. (1994). Stable heterologous expression of hydroxysteroid sulphotransferase in Chinese hamster V79 cells and their use for toxicological investigations. Chemico-Biological Interactions. 92(1-3). 119–128. 38 indexed citations
17.
Kuhn, Anne, Ingrid Bartsch, & Ingrid Grummt. (1990). Specific interaction of the murine transcription termination factor TTF I with class-I RNA polymerases. Nature. 344(6266). 559–562. 97 indexed citations
18.
Pfleiderer, Christa, et al.. (1990). An undecamer DNA sequence directs termination of human ribosomal gene transcription. Nucleic Acids Research. 18(16). 4727–4736. 34 indexed citations
19.
Bartsch, Ingrid, et al.. (1988). Purification and characterization of TTFI, a factor that mediates termination of mouse ribosomal DNA transcription.. Molecular and Cellular Biology. 8(9). 3891–3897. 61 indexed citations
20.
Bartsch, Ingrid, et al.. (1987). Evolutionary changes of sequences and factors that direct transcription termination of human and mouse ribsomal genes.. Molecular and Cellular Biology. 7(7). 2521–2529. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by James T. Radek Breakdown of academic impact, for papers by Kaoru Nishiyama Breakdown of academic impact, for papers by Yves Dubaquié Breakdown of academic impact, for papers by Frédérique Bulle Breakdown of academic impact, for papers by Kimon C. Kanelakis Breakdown of academic impact, for papers by Kelwyn Thomas Breakdown of academic impact, for papers by Marcin Ratajewski Breakdown of academic impact, for papers by Samir Acharya Breakdown of academic impact, for papers by A. Čihák Breakdown of academic impact, for papers by L. Dombrovski
Rankless by CCL
2026